While recent overall breast cancer incidence rates in the US are similar for Black women and White women, US Black women are more likely to be diagnosed with estrogen receptor negative (ER−) breast cancer, which has fewer treatment options and a poorer prognosis [1]. This evidence concerns the gene ESR1 and breast carcinoma.